Abstract
This study compared a range of mammalian CNS expression cassettes in recombinant adeno-associated virus (AAV-2) vectors using strong endogenous promoter sequences, with or without a strong post-regulatory element and polyadenylation signal. Changes in these elements led to transgene expression varying by over three orders of magnitude. In experiments conducted in primary cell culture and in > 100 stereotactically injected rats, we observed highly efficient and stable (> 15 months) gene expression in neurons and limited expression in glia; the highest expression occurred with endogenous, nonviral promoters such as neuron-specific enolase and β-actin. The packaging size of AAV-2 was maximized at 5.7 kb without impairing gene expression, as judged by direct comparison with a number of smaller AAV-2 constructs. The genomic insert size and titer were confirmed by Southern blot and quantitative PCR, and infectivity was tested by particle titer using ELISA with a conformation-dependent epitope that requires the full intact capsid. A packaging and purification protocol we describe allows for high-titer, high-capacity AAV-2 vectors that can transduce over 2 × 105 neurons in vivo per microliter of vector, using the strongest expression cassette.
Original language | English (US) |
---|---|
Pages (from-to) | 1323-1332 |
Number of pages | 10 |
Journal | Gene Therapy |
Volume | 8 |
Issue number | 17 |
DOIs | |
State | Published - 2001 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Molecular Medicine
- Molecular Biology
- Genetics